Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Holger Stark

Showing results (361-370 of 453) with videos related to

Pageof 46
Sort By:
European Journal of Medicinal Chemistry|July 19, 2014
Multi-dimensional target profiling of N,4-diaryl-1,3-thiazole-2-amines as potent inhibitors of eicosanoid metabolismCarmen B Rödl, Dominik Vogt, Simon B M Kretschmer, et al.
Organic Letters|May 8, 2010
First metal-containing histamine H3 receptor ligandsKerstin Sander, Tim Kottke, Claas Hoffend, et al.
International Journal of Molecular Sciences|May 16, 2020
Dual Target Ligands with 4-<i>tert-</i>Butylphenoxy Scaffold as Histamine H<sub>3</sub> Receptor Antagonists and Monoamine Oxidase B InhibitorsDorota Łażewska, Agnieszka Olejarz-Maciej, David Reiner, et al.
Scientific Reports|December 3, 2024
Incorporating immune cell surrogates into a full-thickness tissue equivalent of human skin to characterize dendritic cell activationJohanna Maria Hölken, Anna-Lena Wurz, Katja Friedrich, et al.
Molecules (Basel, Switzerland)|May 27, 2023
Trisubstituted 1,3,5-Triazines as Histamine H<sub>4</sub> Receptor Antagonists with Promising Activity In VivoAgnieszka Olejarz-Maciej, Szczepan Mogilski, Tadeusz Karcz, et al.
Science (New York, N.Y.)|August 27, 2016
Molecular architecture of the Saccharomyces cerevisiae activated spliceosomeReinhard Rauhut, Patrizia Fabrizio, Olexandr Dybkov, et al.
Journal of Medicinal Chemistry|June 9, 2021
Adenosine A<sub>2A</sub>R/A<sub>1</sub>R Antagonists Enabling Additional H<sub>3</sub>R Antagonism for the Treatment of Parkinson's DiseaseStefanie Hagenow, Anna Affini, Elsa Y Pioli, et al.
Chemico-Biological Interactions|August 2, 2019
The dual-active histamine H3 receptor antagonist and acetylcholine esterase inhibitor E100 ameliorates stereotyped repetitive behavior and neuroinflammmation in sodium valproate induced autism in miceNermin Eissa, Sheikh Azimullah, Petrilla Jayaprakash, et al.
International Journal of Molecular Sciences|June 7, 2020
The Dual-Active Histamine H<sub>3</sub> Receptor Antagonist and Acetylcholine Esterase Inhibitor E100 Alleviates Autistic-Like Behaviors and Oxidative Stress in Valproic Acid Induced Autism in MiceNermin Eissa, Sheikh Azimullah, Petrilla Jayaprakash, et al.
Archiv Der Pharmazie|September 26, 2008
Refined docking as a valuable tool for lead optimization: application to histamine H3 receptor antagonistsNicolas Levoin, Thierry Calmels, Olivia Poupardin-Olivier, et al.
Pageof 46

Showing results (361-370 of 453) with videos related to

Sort By:
Pageof 46
European Journal of Medicinal Chemistry|July 19, 2014
Multi-dimensional target profiling of N,4-diaryl-1,3-thiazole-2-amines as potent inhibitors of eicosanoid metabolismCarmen B Rödl, Dominik Vogt, Simon B M Kretschmer, et al.
Organic Letters|May 8, 2010
First metal-containing histamine H3 receptor ligandsKerstin Sander, Tim Kottke, Claas Hoffend, et al.
International Journal of Molecular Sciences|May 16, 2020
Dual Target Ligands with 4-<i>tert-</i>Butylphenoxy Scaffold as Histamine H<sub>3</sub> Receptor Antagonists and Monoamine Oxidase B InhibitorsDorota Łażewska, Agnieszka Olejarz-Maciej, David Reiner, et al.
Scientific Reports|December 3, 2024
Incorporating immune cell surrogates into a full-thickness tissue equivalent of human skin to characterize dendritic cell activationJohanna Maria Hölken, Anna-Lena Wurz, Katja Friedrich, et al.
Molecules (Basel, Switzerland)|May 27, 2023
Trisubstituted 1,3,5-Triazines as Histamine H<sub>4</sub> Receptor Antagonists with Promising Activity In VivoAgnieszka Olejarz-Maciej, Szczepan Mogilski, Tadeusz Karcz, et al.
Science (New York, N.Y.)|August 27, 2016
Molecular architecture of the Saccharomyces cerevisiae activated spliceosomeReinhard Rauhut, Patrizia Fabrizio, Olexandr Dybkov, et al.
Journal of Medicinal Chemistry|June 9, 2021
Adenosine A<sub>2A</sub>R/A<sub>1</sub>R Antagonists Enabling Additional H<sub>3</sub>R Antagonism for the Treatment of Parkinson's DiseaseStefanie Hagenow, Anna Affini, Elsa Y Pioli, et al.
Chemico-Biological Interactions|August 2, 2019
The dual-active histamine H3 receptor antagonist and acetylcholine esterase inhibitor E100 ameliorates stereotyped repetitive behavior and neuroinflammmation in sodium valproate induced autism in miceNermin Eissa, Sheikh Azimullah, Petrilla Jayaprakash, et al.
International Journal of Molecular Sciences|June 7, 2020
The Dual-Active Histamine H<sub>3</sub> Receptor Antagonist and Acetylcholine Esterase Inhibitor E100 Alleviates Autistic-Like Behaviors and Oxidative Stress in Valproic Acid Induced Autism in MiceNermin Eissa, Sheikh Azimullah, Petrilla Jayaprakash, et al.
Archiv Der Pharmazie|September 26, 2008
Refined docking as a valuable tool for lead optimization: application to histamine H3 receptor antagonistsNicolas Levoin, Thierry Calmels, Olivia Poupardin-Olivier, et al.
Pageof 46